stockportfolio.pro
Boston Scientific Corporation P/E Ratio 2007–2025
Boston Scientific Corporation (BSX) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +5.6%/yr over 18 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 49.15 | -31.2% |
| FY 2024 | 71.46 | +32.3% |
| FY 2023 | 54.03 | -47.5% |
| FY 2022 | 102.82 | +67.0% |
| FY 2021 | 61.57 | — |
| FY 2020 | — | — |
| FY 2019 | 13.58 | -54.3% |
| FY 2018 | 29.70 | -90.4% |
| FY 2017 | 309.88 | +258.2% |
| FY 2016 | 86.52 | — |
| FY 2015 | — | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
| FY 2012 | — | — |
| FY 2011 | 18.41 | — |
| FY 2010 | — | — |
| FY 2009 | — | — |
| FY 2008 | — | — |
| FY 2007 | — | — |
Source: Boston Scientific Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Boston Scientific Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBoston Scientific Corporation — frequently asked questions
What is Boston Scientific Corporation's price-to-earnings ratio?
Boston Scientific Corporation (BSX) reported price-to-earnings ratio of 49.15 for fiscal year 2025, per its SEC filings.
How has Boston Scientific Corporation's price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, BSX's price-to-earnings ratio grew at roughly 5.6% per year (compound annual rate), from 18.41 to 49.15.
Where does this data come from?
Figures are computed from Boston Scientific Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.